Latest Osteoarthritis News

Page 4 of 4

Cynata Advances with Positive Diabetic Foot Ulcer Trial and $10.5m Cash Buffer

Cynata Therapeutics reports encouraging Phase 1 results for its diabetic foot ulcer treatment CYP-006TK, alongside a strengthened balance sheet and ongoing clinical progress.

Ada Torres

30 Jan 2025

Paradigm Biopharma Boosts Cash by $6.3M to Power Osteoarthritis Trial

Paradigm Biopharmaceuticals has secured a $6.3 million R&D Tax Incentive refund, lifting its cash reserves to $31 million and reinforcing its push into Phase 3 osteoarthritis clinical trials.

Victor Sage

24 Jan 2025